The mechanistic basis for psoriasis immunopathogenesis: Translating genotype to phenotype. Report of a workshop, Venice, 2012

British Journal of Dermatology

Volumn 169, Issue 2, 2013, Pages 283-286

  Bachelez, H ^a   Viguier, M ^b   Tebbey, P W ^c   Lowes, M ^d   Suarez Farinas M ^d   Costanzo, A ^e   Nestle, F O ^f  

^a SAINT LOUIS HOSPITAL   (France)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

^c International Psoriasis Council   (United States)

^d ROCKEFELLER UNIVERSITY   (United States)

^e SAPIENZA UNIVERSITY OF ROME   (Italy)

^f KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 17; INTERLEUKIN 17F; INTERLEUKIN 23;

ANKYLOSING SPONDYLITIS; ARTICLE; GENETIC ASSOCIATION; GENOTYPE; HOMEOSTASIS; HUMAN; IMMUNOPATHOGENESIS; IMMUNOREGULATION; MEDICAL RESEARCH; NON PROFIT ORGANIZATION; PHENOTYPE; PRIORITY JOURNAL; PSORIASIS; TH17 CELL; TREATMENT RESPONSE; WORKSHOP;

ADAPTIVE IMMUNITY; CYTOKINES; GENOTYPE; HUMANS; IMMUNITY, INNATE; PHENOTYPE; PSORIASIS; RECEPTORS, CYTOKINE;

EID: 84881575868     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/bjd.12347     Document Type: Article

References (22)

1. Rahman P, Sun S, Peddle L, et al,. Association between the interleukin 1 family gene cluster and psoriatic arthritis. Arthritis Rheum 2006; 54: 2321-5.
2. Towne JE, Sims JE,. IL-36 in psoriasis. Curr Opin Pharmacol 2012; 12: 486-90.
3. Marrakchi S, Guigue P, Renshaw BR, et al,. Interleukin-36-receptor antagonist deficiency and generalized pustular psoriasis. N Engl J Med 2011; 365: 620-8.
4. Onoufriadis A, Simpson MA, Pink AE, et al,. Mutations in IL36RN/IL1F5 are associated with the severe episodic inflammatory skin disease known as generalized pustular psoriasis. Am J Hum Genet 2011; 89: 432-7.
5. Tortola L, Rosenwald E, Abel B, et al,. Psoriasiform dermatitis is driven by IL-36-mediated DC-keratinocyte crosstalk. J Clin Invest 2012; 122: 3965-76.
6. Nestle FO, Kaplan DH, Barker J,. Psoriasis. N Engl J Med 2009; 361: 496-509.
7. Di Cesare A, Di Meglio P, Nestle FO,. The IL-23/Th17 axis in the immunopathogenesis of psoriasis. J Invest Dermatol 2009; 129: 1339-50.
8. Capon F, Di Meglio P, Szaub J, et al,. Sequence variants in the genes for the interleukin-23 receptor (IL23R) and its ligand (IL12B) confer protection against psoriasis. Hum Genet 2007; 122: 201-6.
9. Cargill M, Schrodi SJ, Chang M, et al,. A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes. Am J Hum Genet 2007; 80: 273-90.
10. Nair RP, Callis Duffin K, Helms C, et al,. Genome wide scan reveals association of psoriasis with IL-23 and NF-κB pathways. Nat Genet 2009; 41: 199-204.
11. Di Meglio P, Di Cesare A, Laggner U, et al,. The IL23R R381Q gene variant protects against immune-mediated diseases by impairing IL-23-induced Th17 effector response in humans. PLoS ONE 2011; 6: e17160.
12. Tian S, Krueger JG, Li K, et al,. Meta-analysis derived (MAD) transcriptome of psoriasis defines the 'core' pathogenesis of disease. PLoS ONE 2012; 7: e44274.
13. Suárez-Fariñas M, Li K, Fuentes-Duculan J, et al,. Expanding the psoriasis disease profile: interrogation of the skin and serum of patients with moderate-to-severe psoriasis. J Invest Dermatol 2012; 132: 2552-64.
14. Suárez-Fariñas M, Fuentes-Duculan J, Lowes MA, et al,. Resolved psoriasis lesions retain expression of a subset of disease-related genes. J Invest Dermatol 2011; 131: 391-400.
15. Krueger JG, Fretzin S, Suárez-Fariñas M, et al,. IL-17A is essential for cell activation and inflammatory gene circuits in subjects with psoriasis. J Allergy Clin Immunol 2012; 130: 145-54.
16. Jabbari A, Suárez-Fariñas M, Dewell S, et al,. Transcriptional profiling of psoriasis using RNA-seq reveals previously unidentified differentially expressed genes. J Invest Dermatol 2012; 132: 246-9.
17. Zenz R, Eferl R, Kenner L, et al,. Psoriasis-like skin disease and arthritis caused by inducible epidermal deletion of Jun proteins. Nature 2005; 437: 369-75.
18. Bollrath J, Greten FR,. IKK/NF-kappaB and STAT3 pathways: central signalling hubs in inflammation-mediated tumour promotion and metastasis. EMBO Rep 2009; 10: 1314-19.
19. Wertz IE, Dixit VM,. Signaling to NF-kappaB: regulation by ubiquitination. Cold Spring Harb Perspect Biol 2010; 2: a003350.
20. Wertz IE, O'Rourke KM, Zhou H, et al,. De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-κB signalling. Nature 2004; 430: 694-9.
21. Lippens S, Lefebvre S, Gilbert B, et al,. Keratinocyte-specific ablation of the NF-κB regulatory protein A20 (TNFAIP3) reveals a role in the control of epidermal homeostasis. Cell Death Differ 2011; 18: 1845-53.
22. Marinari B, Moretti F, Botti E, et al,. The tumor suppressor activity of IKKalpha in stratified epithelia is exerted in part via the TGF-beta antiproliferative pathway. Proc Natl Acad Sci USA 2008; 105: 17091-6.